Finally, we evaluated fluoxetine effectiveness in the human A549 lung carcinoma cells stably overexpressing the SARS-CoV-2 receptor ACE2, and the protease TMPRSS2 to increase their permissiveness to SARS-CoV-2 infection [51]. This evidence concerns the gene ACE2 and lung carcinoma.